Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preparation of mean drug concentration--time curves in plasma. A study on the frequency distribution of pharmacokinetic parameters.

Literature DB >> 4042238

Preparation of mean drug concentration--time curves in plasma. A study on the frequency distribution of pharmacokinetic parameters.

E Mizuta, A Tsubotani.

Abstract

Mesh：

Substances：

Year: 1985 PMID： 4042238 DOI： 10.1248/cpb.33.1620

Source DB: PubMed Journal: Chem Pharm Bull (Tokyo) ISSN： 0009-2363 Impact factor: 1.645

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas.

Authors: David M Peereboom; Jeffrey G Supko; Kathryn A Carson; Tracy Batchelor; Surasak Phuphanich; Glenn Lesser; Tom Mikkelsen; Tom Mikkelson; Joy Fisher; Serena Desideri; Xiaoying He; Stuart A Grossman
Journal: J Neurooncol Date: 2010-05-07 Impact factor: 4.130

2. Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma.

Authors: L B Nabors; J G Supko; M Rosenfeld; M Chamberlain; S Phuphanich; T Batchelor; S Desideri; X Ye; J Wright; S Gujar; S A Grossman
Journal: Neuro Oncol Date: 2011-09-27 Impact factor: 12.300

3. Evaluation of hepatic function using the pharmacokinetics of a therapeutically administered drug. Application to the immunosuppressant cyclosporin.

Authors: W Weber; M Looby; J Brockmöller
Journal: Clin Pharmacokinet Date: 1992-07 Impact factor: 6.447

4. Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Authors: Matthias Holdhoff; Xiaobu Ye; Jeffrey G Supko; Louis B Nabors; Arati S Desai; Tobias Walbert; Glenn J Lesser; William L Read; Frank S Lieberman; Martin A Lodge; Jeffrey Leal; Joy D Fisher; Serena Desideri; Stuart A Grossman; Richard L Wahl; David Schiff
Journal: Neuro Oncol Date: 2017-06-01 Impact factor: 12.300

5. NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.

Authors: David M Peereboom; Manmeet S Ahluwalia; Xiaobu Ye; Jeffrey G Supko; Sarah L Hilderbrand; Surasak Phuphanich; L Burt Nabors; Myrna R Rosenfeld; Tom Mikkelsen; Stuart A Grossman
Journal: Neuro Oncol Date: 2013-01-17 Impact factor: 12.300

6. Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma.

Authors: Stuart A Grossman; Jeffrey Olson; Tracy Batchelor; David Peereboom; Glenn Lesser; Serena Desideri; Xiaobu Ye; Tarek Hammour; Jeffrey G Supko
Journal: Neuro Oncol Date: 2008-02-20 Impact factor: 12.300

7. A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies.

Authors: Joseph P Eder; Rocio Garcia-Carbonero; Jeffrey W Clark; Jeffrey G Supko; Thomas A Puchalski; David P Ryan; Pamela Deluca; Antoinette Wozniak; Angela Campbell; John Rothermel; Patricia LoRusso
Journal: Invest New Drugs Date: 2004-04 Impact factor: 3.850